Genetic markers of predisposition to increased anxiety

Bulletin of Experimental Biology and Medicine

Volumn 146, Issue 6, 2008, Pages 774-778

  Kulikova, M A ^a   Trushkin, E V ^a   Timofeeva, M A ^a   Shlepzova, V A ^a   Schegolkova, J V ^a   Maluchenko, N V ^a   Tonevitsky, A G ^a  

^a All Russian Institute of Physical Culture and Sports   (Russian Federation)

Author keywords

Anxiety; Dopamine; Dopamine receptor DRD2; Dopamine transporter DAT; Striatum

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER;

ADULT; ANXIETY DISORDER; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CORPUS STRIATUM; EXTRACELLULAR SPACE; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOLOGIC ASSESSMENT;

ADOLESCENT; ADULT; ANXIETY; CATECHOL O-METHYLTRANSFERASE; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MODELS, BIOLOGICAL; MODELS, THEORETICAL; RECEPTORS, DOPAMINE D2; YOUNG ADULT;

EID: 67349208001     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-009-0373-x     Document Type: Article

References (15)

1. Diagnostics of Emotional-Ethical Development, Ed. I. B. Dermanova [in Russian], St. Petersburg (2002), P. 126-128.
2. M. A. Kulikova, N.V. Maluchenko, M.A. Timofeeva, et al., Bull. Eksp. Biol. Med., 145, No. 1, 68-90 (2008).
3. M. Beniot-Marand, E. Borrelli, and F. Gonon, J. Neurosci., 21, No. 23, 9134-9141 (2001).
4. J. Chen, B. K. Lipska, N. Halim, et al., Am. J. Hum. Genet., 75, No. 5, 807-821 (2004).
5. S. J. Cragg and M. E. Rice, Trends Neurosci., 27, No. 5, 270-277 (2004).
6. C. C. Hong, H. J. Thompson, and C. Jiang, et al., Cancer Epidemiol. Biomarkers Prev., 12, No. 9, 838-847 (2003).
7. A. Laakso, H. Vilkman, J. Kajander, et al., Am. J. Psychiatry, 157, 290-292 (2000).
8. D. Martinez, J. Gelernter, A. Abi-Dargham, et al., Neuropsychopharmacology, 24, 553-560 (2001).
9. E. P. Noble, R. E. Noble, T. Ritchie, et al., Int. J. Eat. Disord., 15, 205-217 (1994).
10. A. Reif and K. P. Lesch, Behav. Brain. Res., 139, Nos. 1-2, 1-20 (2003).
11. A. Sano, K. Kondoh, Y. Kakimoto, and I. Kondo, Hum. Genet., 91, No. 4, 405-406 (1993).
12. S. R. Sesack, C. Aoki, and V. M. Pickel, J. Neurosci., 14, No. 1, 88-106 (1994).
13. M. B. Stein, K. L. Jang, and W. J. Livesley, Am. J. Psychiatr., 156, No. 2, 246-251 (1999).
14. J. Thompson, N. Thomas, A. Singleton, et al., Pharmacogenetics, 7, No. 6, 479-484 (1997).
15. D. J. Vandenbergh, A. M. Persico, A.L. Hawkins, et al., Genomics, 14, No. 4, 1104-1106 (1992).